|

Nivolumab 40mg Clinical Trials

1 actively recruiting trial

Also known as: Opdivo

Pipeline

Phase 3: 1

Top Sponsors

  • Dr Arvindran A/L Alaga1

Indications

  • Locally Advanced/Metastatic NSCLC1
  • NSCLC (Non-small Cell Lung Carcinoma)1
  • First Line Therapy1
  • Lung Cancer1
  • Cancer1

Other1 trial

Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.